Stephen Bevan Shrewsbury

Former Chief Medical Officer & Vice President-Clinical Affairs at MAP Pharmaceuticals, Inc.

Stephen Bevan Shrewsbury

Stephen Bevan Shrewsbury

Former Chief Medical Officer & Vice President-Clinical Affairs at MAP Pharmaceuticals, Inc.

Overview

RelSci Relationships

895

Number of Boards

2

Birthday

1957

Age

63

Relationships

View Relationship Details

RelSci Relationships are individuals Stephen Bevan Shrewsbury likely has professional access to. A relationship does not necessarily indicate a personal connection.

Christopher A. Viehbacher

Co-Founder at Gurnet Point Capital LLC

Relationship likelihood: Strong

Richard Brook Sykes

Executive Chairman at PDS Operating Corp.

Relationship likelihood: Strong

David Chernoff

Chief Medical Officer at SetPoint Medical Corp.

Relationship likelihood: Strong

Jean-Pierre Garnier

Operating Partner at Advent International LLC

Relationship likelihood: Strong

Regina Hodits

Managing Partner at Wellington Partners GmbH

Relationship likelihood: Strong

Charles A. Sanders

Executive Officer at The University of North Carolina at Chapel Hill

Relationship likelihood: Strong

Michel G. Lurquin

Associate at Biométhodes SA

Relationship likelihood: Strong

Marshall Hayward

Director & Chief Scientific Officer at Jupiter Orphan Therapeutics, Inc.

Relationship likelihood: Strong

Giuseppe S. Alvaro

Co-Founder at Autifony Therapeutics Ltd.

Relationship likelihood: Strong

Maury M. Tepper, III

Chairman, North America New Member Recruitment Task Force at International Trademark Association, Inc.

Relationship likelihood: Strong

Reveal deeper insights into your organization's relationships
with RelSci Contact Aggregator.

Empower Your Business Applications with Industry-Leading
Relationship Data from the RelSci API.

Get Contact Information on the
World's Most Influential Decision Makers.

Discover the Power of Your Network with
RelSci Premium Products.

In The News

PR Newswire

October 8, 2020

Impel NeuroPharma Presents Data From Pivotal Phase 3 Registration Study Of INP104 For The Treatment Of Acute Migraine At 2020 Migraine Trust Virtual Symposium; 66.3% of Patients Reported Pain Relief Within Two Hours of Treatment with Rapid Uptake via the

ENP Newswire

July 10, 2020

-University of Southampton: New research to focus on the COVID-19-driven aftermath of working from home

PR Newswire

June 30, 2020

Impel NeuroPharma Announces Publication of Positive Results of SNAP 101 Study for INP105 for the Treatment of Acute Agitation in The Journal of Clinical Psychiatry; Study Shows INP105 Achieves Rapid Absorption Which May Provide An Effective, Convenient, &

PR Newswire

June 15, 2020

Impel NeuroPharma Presents Data From INP104 Clinical Program In Acute Migraine At The 2020 American Headache Society (AHS) Virtual Annual Scientific Meeting; Four Scientific Poster Presentations Support the Potential of INP104 to Fulfill Key Unmet Needs a

PR Newswire

June 10, 2020

Impel NeuroPharma Announces Primary Objectives Met In Pivotal Phase 3 Registration Study Of INP104 For The Treatment Of Acute Migraine; Exploratory Efficacy Data Reveal INP104 Resulted in Pain Relief in 66.3% of Patients and Pain Freedom in 38% of Patient

Paths to Stephen Bevan Shrewsbury

Potential Connections via
Relationship Science

You

Stephen Bevan Shrewsbury

Former Chief Medical Officer & Vice President-Clinical Affairs at MAP Pharmaceuticals, Inc.

Education

Bachelor of Medicine Degree

The University of Liverpool

The University of Liverpool operates as a university. It offers post graduate research, foundation courses, continuing and professional development, online study, and doctoral college. The company was founded in 1881 and is headquartered in Liverpool, the United Kingdom.

Career History

Head-Senior Clinical Program

1993 - 2002

GlaxoSmithKline Plc

GlaxoSmithKline Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the following segments: Pharmaceuticals, Vaccines, Consumer Healthcare, and Corporate Executive Team (CET). The Pharmaceuticals segment focuses on developing medicines in respiratory and infectious diseases, oncology, and immuno-inflammation. The Vaccines segment produces pediatric and adult vaccines to prevent a range of infectious diseases including, hepatitis A and B, diphtheria, tetanus and whooping cough, measles, mumps and rubella, polio, typhoid, influenza, and bacterial meningitis. The Consumer Healthcare segment develops and markets brands in the oral health, pain relief, respiratory, nutrition and gastro intestinal, and skin health categories. The CET segment refers to the management of business activities. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.

Chief Medical Officer & Senior Vice President-Preclinical

2009 - 2011

Sarepta Therapeutics, Inc.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980 and is headquartered in Cambridge, MA.

Senior Director-Clinical Development

2002 - 2005

Chiron Corp.

Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA.

Boards & Committees

Director

Current

BioXpertz LLC

Director

1993 - 2002

GlaxoSmithKline Plc

GlaxoSmithKline Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the following segments: Pharmaceuticals, Vaccines, Consumer Healthcare, and Corporate Executive Team (CET). The Pharmaceuticals segment focuses on developing medicines in respiratory and infectious diseases, oncology, and immuno-inflammation. The Vaccines segment produces pediatric and adult vaccines to prevent a range of infectious diseases including, hepatitis A and B, diphtheria, tetanus and whooping cough, measles, mumps and rubella, polio, typhoid, influenza, and bacterial meningitis. The Consumer Healthcare segment develops and markets brands in the oral health, pain relief, respiratory, nutrition and gastro intestinal, and skin health categories. The CET segment refers to the management of business activities. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.

Other Affiliations

Stephen Bevan Shrewsbury is affiliated with GlaxoSmithKline Plc, Sarepta Therapeutics, Inc., Chiron Corp., MAP Pharmaceuticals, Inc., Adamas Pharmaceuticals, Inc., Aquinox Pharmaceuticals, Inc., Neoleukin Therapeutics, Inc., BioXpertz LLC, GlaxoSmithKline Plc

Stay informed and up-to-date on your network with RelSci news and business alerting service. Nurture your network and further your business goals with smart intelligence on the people and companies that matter most to you.

Browse in-depth profiles on 12 million influential people and organizations. Find RelSci relationships, employment history, board memberships, donations, awards, and more.

Explore notable alumni from top universities and organizations. Expand your fundraising pool and make warm introductions to potential new business connections.

Harness the power of your relationships with RelSci Pro, the powerful platform for identifying relationship-driven business opportunities and connections that can propel your career forward.

Stay informed and up-to-date on your network with RelSci news and business alerting service. Nurture your network and further your business goals with smart intelligence on the people and companies that matter most to you.

Browse in-depth profiles on 12 million influential people and organizations. Find RelSci relationships, employment history, board memberships, donations, awards, and more.

Explore notable alumni from top universities and organizations. Expand your fundraising pool and make warm introductions to potential new business connections.

Harness the power of your relationships with RelSci Pro, the powerful platform for identifying relationship-driven business opportunities and connections that can propel your career forward.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Stephen Bevan Shrewsbury. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Stephen Bevan Shrewsbury's profile does not indicate a business or promotional relationship of any kind between RelSci and Stephen Bevan Shrewsbury.